LSD1/KDM1A and GFI1B repress endothelial fate
Vol. 109 No. 12 (2024): December, 2024 https://doi.org/10.3324/haematol.2024.285214
Pharmacokinetic–Pharmacodynamic Modelling in Hemophilia A
European Journal of Drug Metabolism and Pharmacokinetics (2024) 49:191–205 https://doi.org/10.1007/s13318-024-00876-6
A Generative and Causal Pharmacokinetic Model for Factor VIII in Hemophilia
CLINICAL PHARMACOLOGY & THERAPEUTICS | VOLUME 0 NUMBER 0 | Month 2024 doi:10.1002/cpt.3203
PBPK modeling of recombinant factor IX Fc fusion protein
CPT Pharmacometrics Syst Pharmacol. 2024;13:1630–1640 Lees hier
Platelet proteomics profiling in sitosterolemia suggests
Blood Advances 28 MAY 2024 • VOLUME 8, NUMBER 10
Joint status of patients with nonservere hemophilia A
J Thromb Haemost. 2022;20:1126–1137 DOI: 10.1111/jth.15676
Blood coagulation and beyond
Thromb Haemost 2023; 123:808-839 Het article kan HIER gelezen worden
Ethical aspects of hemophilia gene therapie
RPTH 2023;7:e102237 De volledige tekst kan HIER gelezen worden.
Verbetering van de diagnostiek en behandeling
NVTH - jaargang 20 - juni 2023
Desmopressin to prevent and treat bleeding
J Thromb Haemost. 2023;▪:1–14